We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Expert Opinion / Cases · May 25, 2021

Next Steps for Recurrent HR+ Ductal Carcinoma

Written by
Ana C. Sandoval Leon MD

 

Discuss This item Follow

No comments yet, be the first to start the discussion!

  • Jose A Garcia-Saenz

    Retest immunochemistry study in the liver biopsy, first.


  • Carlos Calderon

    After reviewing the immunohistochemistry, if local luminal b and triple negative metastasis are confirmed then surgical control of local recurrence, followed by radiotherapy and bilateral oophorectomy. Start capecitabine. A genetic panel would be important.


  • iveta andrezalova

    Capecitabine


  • oscar aballay

    Capecitabine


  • Jul 27, 2021

    Pending Moderator approval.
    Delete

Further Reading